Brief: Kinnate BiopharmaBoard Got Letter From Funds Affiliated With Foresite Capital Management
15/11/2023 15:19
Nov 15 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA- ON NOV 13, BOARD GOT LETTER FROM FUNDS
AFFILIATED WITH FORESITE CAPITAL MANAGEMENT AND FUNDS AFFILIATED
WITH ORBIMED ADVISORS
* KINNATE BIOPHARMA: LETTER INDICATED INTENT TO EXPLORE
POTENTIAL
ACQUISITION OF ALL OUTSTANDING SHARES OF CO NOT ALREADY OWNED IN
GOING-PRIVATE DEAL
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview